tiprankstipranks
Trending News
More News >
3D Medicines, Inc. (HK:1244)
:1244
Hong Kong Market

3D Medicines, Inc. (1244) Financial Statements

Compare
2 Followers

3D Medicines, Inc. Financial Overview

3D Medicines, Inc.'s market cap is currently HK$999.14M. The company's EPS TTM is HK$-0.808; its P/E ratio is ―; 3D Medicines, Inc. is scheduled to report earnings on March 27, 2025, and the estimated EPS forecast is HK$―. See an overview of income statement, balance sheet, and cash flow financials.
Dec 23Dec 22Dec 21Dec 20
Income Statement
Total Revenue¥ 634.95M¥ 567.39M¥ 60.26M¥ 0.00
Gross Profit¥ 524.01M¥ 525.18M¥ 55.98M¥ 0.00
Operating Income¥ -497.25M¥ -996.47M¥ -1.46B¥ -627.48M
EBITDA¥ -529.23M¥ -1.03B¥ -1.45B¥ -303.35M
Net Income¥ -524.70M¥ -1.02B¥ -1.43B¥ -635.38M
Balance Sheet
Cash & Short-Term Investments¥ 996.58M¥ 942.03M¥ 824.48M¥ 414.26M
Total Assets¥ 1.43B¥ 1.33B¥ 1.06B¥ 496.22M
Total Debt¥ 282.43M¥ 175.70M¥ 58.74M¥ 20.37M
Net Debt¥ -384.05M¥ -521.04M¥ -715.57M¥ -393.89M
Total Liabilities¥ 558.20M¥ 436.65M¥ 3.33B¥ 1.77B
Stockholders' Equity¥ 936.74M¥ 943.00M¥ -2.24B¥ -1.27B
Cash Flow
Free Cash Flow¥ -150.74M¥ -332.76M¥ -433.46M¥ -289.48M
Operating Cash Flow¥ -144.41M¥ -278.78M¥ -377.08M¥ -278.33M
Investing Cash Flow¥ -187.58M¥ -242.11M¥ -98.87M¥ -20.48M
Financing Cash Flow¥ 304.51M¥ 408.41M¥ 840.08M¥ 607.39M
Currency in CNY

3D Medicines, Inc. Earnings and Revenue History

3D Medicines, Inc. Debt to Assets

3D Medicines, Inc. Cash Flow

3D Medicines, Inc. Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis